Deed #13: Grant award

Hypercholesterolemia medication tailored for your genotype. DRA has chosen Wilma Kiander, M.Sc. (Pharm), as the recipient of the €15,000 research grant awarded by the company to celebrate its 15th anniversary.

The subject of Wilma Kiander’s research is the impact of genotype on the efficacy and safety of hypercholesterolemia therapies: the effect of rare OATP1B1 transporter protein variants on the pharmacokinetics of rosuvastatin. She is performing her doctoral studies under the guidance of Heidi Kidron and Mikko Niemi.

The grant was allocated for utilisation of pharmacogenomics in drug therapies, and the impact of the research on public health and society was emphasized in the selection process.

The recipient of the DRA 15th anniversary grant was announced at the educational event on genomic information and individualized drug therapy organized by Pharmaceutical Information Centre.

More DRA's good deeds